CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.Business Wire • 02/11/26
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 01/30/26
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudBusiness Wire • 01/30/26
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026GlobeNewsWire • 01/29/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRXGlobeNewsWire • 01/27/26
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationGlobeNewsWire • 01/22/26
CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 GuidanceGlobeNewsWire • 01/12/26
CVRx Announces Implementation of New Category I CPT Codes for Barostim TherapyGlobeNewsWire • 01/06/26
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025GlobeNewsWire • 10/22/25
CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 07/28/25
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains?Zacks Investment Research • 07/17/25